Dr. Theoret is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10903 New Hampshire Ave
Building 22, Room 2218
Silver Spring, MD 20993Phone+1 301-796-4099
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2005 - 2009
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2002 - 2005
Pennsylvania State University College of MedicineClass of 2001
Certifications & Licensure
MD State Medical License 2005 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 78 citationsFDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung CancerLuckson Mathieu, Sujay Shah, Lee Pai-Scherf, Erin Larkins, Jonathon Vallejo
The Oncologist. 2021-05-01 - 12 citationsEligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trials.Bindu Kanapuru, Laura L Fernandes, Andrea Baines, Rachel Ershler, Vishal Bhatnagar
Blood. 2023-07-20 - 457 citationsIL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T CellsChristopher A. Klebanoff, Steven E. Finkelstein, Deborah R. Surman, Michael K. Lichtman, Luca Gattinoni
Proceedings of the National Academy of Sciences of the United States of America. 2004-02-17
Authored Content
- How to Get the Dose RightApril 2022
Press Mentions
SITC Announces Co-Sponsored Workshop with U.S. Food and Drug Administration on Immune-Modified Response Criteria in Cancer Immunotherapy Clinical TrialsOctober 12th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
